jueves, 19 de marzo de 2015

Deaths Associated with Respiratory Syncytial and Influenza Viruses among Persons ≥5 Years of Age in HIV-Prevalent Area, South Africa, 1998–20091 - Volume 21, Number 4—April 2015 - Emerging Infectious Disease journal - CDC

FULL-TEXT ►

Deaths Associated with Respiratory Syncytial and Influenza Viruses among Persons ≥5 Years of Age in HIV-Prevalent Area, South Africa, 1998–20091 - Volume 21, Number 4—April 2015 - Emerging Infectious Disease journal - CDC





Volume 21, Number 4—April 2015

CME ACTIVITY - Research

Deaths Associated with Respiratory Syncytial and Influenza Viruses among Persons ≥5 Years of Age in HIV-Prevalent Area, South Africa, 1998–20091

Stefano TempiaComments to Author , Sibongile Walaza, Cecile Viboud, Adam L. Cohen, Shabir A. Madhi, Marietjie Venter, Claire von Mollendorf, Jocelyn Moyes, Johanna M. McAnerney, and Cheryl Cohen
Author affiliations: National Health Laboratory Service, Johannesburg, South Africa (S. Tempia, S. Walaza, S.A. Madhi, C. von Mollendorf, J. Moyes, J.M. McAnerney, C. Cohen)Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Tempia, A.L. Cohen)Centers for Disease Control and Prevention, Pretoria, South Africa (S. Tempia, A.L. Cohen, M. Venter)National Institutes of Health, Bethesda, Maryland, USA (C. Viboud);University of the Witwatersrand, Johannesburg (S.A. Madhi, J. Moyes, C. Cohen)

Abstract

We estimated deaths attributable to influenza and respiratory syncytial virus (RSV) among persons >5 years of age in South Africa during 1998–2009 by applying regression models to monthly deaths and laboratory surveillance data. Rates were expressed per 100,000 person-years. The mean annual number of seasonal influenza–associated deaths was 9,093 (rate 21.6). Persons >65 years of age and HIV-positive persons accounted for 50% (n = 4,552) and 28% (n = 2,564) of overall seasonal influenza-associated deaths, respectively. In 2009, we estimated 4,113 (rate 9.2) influenza A(H1N1)pdm09–associated deaths. The mean of annual RSV-associated deaths during the study period was 511 (rate 1.2); no RSV-associated deaths were estimated in persons >45 years of age. Our findings support the recommendation for influenza vaccination of older persons and HIV-positive persons. Surveillance for RSV should be strengthened to clarify the public health implications and severity of illness associated with RSV infection in South Africa.
Influenza virus and respiratory syncytial virus (RSV) infections cause substantial numbers of illness and deaths globally each year; the highest rates are in young children and persons >65 years of age (14). However, national estimates of deaths caused by these infections remain scarce in Africa.
Available data suggest that the severity of influenza and RSV illness is higher among HIV-positive persons (5–11). During 2009 in South Africa, ≈5.1 million HIV-positive persons >5 years of age were reported (12). The highest prevalence was in the 20–44-year age group, among whom HIV prevalence increased from 10% in 1998 to 24% in 2009. Coverage with highly active antiretroviral therapy (HAART) among HIV-positive persons slowly increased from 2004 to reach a plateau of ≈14% in 2009 (12). The lowest reported occurrence of HIV infection in the country was in persons >75 years of age; data showed a 0.6% prevalence and 26% HAART coverage for this group in 2009 (12). Pneumonia ranked within the top 5 leading causes of death among persons >15 years of age in South Africa in 2009 (13).
Clarification of the annual number of deaths associated with influenza and RSV in South Africa could assist with the prioritization of interventions. Because influenza virus and RSV infections are rarely confirmed by laboratory diagnosis and related deaths may be attributed to co-morbid conditions or secondary infections, we applied modeling approaches (14) to estimate seasonal and pandemic influenza- and RSV-associated deaths among persons >5 years of age during 1998–2009.

Dr. Stefano Tempia is a veterinary epidemiologist working for the Influenza Division, US Centers for Disease Control and Prevention, and based at the National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa. His research interests are focused on infectious diseases.

Acknowledgment

References

  1. Simonsen LClarke MJSchonberger LBArden NHCox NJFukuda KPandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis1998;178:5360DOIPubMed
  2. Zhou HThompson WWViboud CGRingholz CMCheng PYSteiner CHospitalization associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis2012;54:142736DOIPubMed
  3. Thompson WWShay DKWeintraub EBrammer LCox NAnderson LJMortality associated with influenza and respiratory syncytial virus in the United States. JAMA2003;289:17986DOIPubMed
  4. Hardelid PPebody RAdrews NMortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999–2010.Influenza Other Respir Viruses2013;7:3545DOIPubMed
  5. Moyes JCohen CPretorius MGroom Mvon Gottberg AWolter NEpidemiology of respiratory syncytial virus–associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010–2011. J Infect Dis2013;208(Suppl 3):S21726DOIPubMed
  6. Sheth ANAlthoff KNBrooks JTInfluenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis.2011;52:21927DOIPubMed
  7. Madhi SASchoub BSimmank KBlackburn NKlugman KPIncreased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr2000;137:7884DOIPubMed
  8. Madhi SARamasamy NBessellar TGSaloojee HKlugman KPLower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr Infect Dis J2002;21:2917DOIPubMed
  9. Ope MOKatz MAAura BGikunju SNjenga MKNg’ang’a ZRisk factors for hospitalized seasonal influenza in rural Western Kenya. PLoS ONE.2011;6:e20111DOIPubMed
  10. Madhi SAKuwanda LCutland CKlugman KPFive-year Cohort study of hospitalisation for respiratory syncytial virus associated lower respiratory tract infection in African children. J Clin Virol2006;36:21521DOIPubMed
  11. Cohen CMoyes JTempia SGroom MWakaza SPretorius MSevere influenza-associated lower respiratory tract infection in a high HIV prevalence setting, South Africa, 2009–2011. Emerg Infect Dis2013;19:176674.PubMed
  12. Actuarial Society of South Africa (ASSA). AIDS and demographic model [cited 2012 Sep 20]. http://aids.actuarialsociety.org.za/ASSA2008-Model-3480.htm
  13. Statistics South Africa. Mortality and cause of death in South Africa 2009: Findings from death notification. Pretoria, Statistics South Africa, 2009[cited 2013 June 12]. http://www.statssa.gov.za/publications/P03093/P030932009.pdf.
  14. Tempia SWalaza SViboud CCohen ALMadhi SAVenter MMortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting—South Africa, 1998–2009. Clin Infect Dis2014;58:12419DOIPubMed
  15. Statistics South Africa. Mortality and causes of death in South Africa: findings from death notifications, 1998–2009. Pretoria (South Africa): Statistics South Africa; 2009.
  16. Statistics South Africa. Population statistics [cited 2012 Sep 21]. http://www.statssa.gov.za/publications/populationstats.asp
  17. McAnerney JMCohen CMoyes JBesselaar TGBuys ASchoub BDTwenty-five years of outpatient influenza surveillance in South Africa (1984–2008). J Infect Dis2012;206(Suppl1):S1538DOIPubMed
  18. Cohen CSimonsen LSample JKang JWMiller MMadhi SAInfluenza-related mortality among adults aged 25–54 years with AIDS in South Africa and the United States of America. Clin Infect Dis2012;55:9961003DOIPubMed
  19. Cohen CSimonsen LKang JWMiller MMcAnerney JBlumberg LElevated influenza-related excess mortality in South African elderly individuals, 1998–2005. Clin Infect Dis2010;51:13629DOIPubMed
  20. Nunes BViboud CMachado ARingholz CRebelo-de-Andrade HNoqueira PExcess mortality associated with influenza epidemics in Portugal, 1980 to 2004. PLoS ONE2011;6:e20661DOIPubMed
  21. Lemaitre MCarrat FRey GMiller MSimonsen LViboud CMortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS ONE2012;7:e45051DOIPubMed
  22. Charu VChowell GPalacio Mejia LSEchevarría-Zuno SBorja-Aburto VHSimonsen LMortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis2011;53:98593DOIPubMed
  23. van den Wijngaard CCvan Asten LKoopmans MPGvan Pelt WNagelkerke NJDWielders CCComparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children. PLoS ONE2012;7:e31197DOIPubMed
  24. Charu VSimonsen LLustig RSteiner CViboud CMortality burden of the 2009–10 influenza pandemic in the United States: improving the timeliness of influenza severity estimates using inpatient mortality records. Influenza Other Respir Viruses2013;7:86371DOIPubMed
  25. Freitas ARRFrancisco PMSBDonalisio MRMortality associated with influenza in tropics, State of São Paulo, Brazil, from 2002 to 2011: the pre-pandemic, pandemic and post-pandemic periods. Influenza Res Treat2013;2013:696274DOIPubMed
  26. Dawood FSJuliano ADReed CMeltzer MIShay DKCheng PYEstimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling approach. Lancet Infect Dis2012;12:68795DOIPubMed
  27. Charu VSimonsen LJordan RSteiner CViboud C. Contrasting the impact of influenza and respiratory syncytial virus (RSV) in the US. Proceeding of the incidence, severity and impact of influenza conference. Munich, 5–8 September 2012 [cited 12 June 2013].http://creativestage.nucleusclient.com/isirv/Incidence/Viboud_WEB_Version.pdf
  28. Kyeyagalire RTempia SCohen ALSmith ADMcAnerney JMDermaux-Msimang VHospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007–2012. BMC Infect Dis2014;14:694DOIPubMed
  29. Lee NLui GCWong KTLi TCTse ECChan JYHigh morbidity and mortality in adults hospitalized for respiratory syncytial virus infection. Clin Infect Dis2013;57:106977DOIPubMed
  30. Falsey ARMcElhaney JEBeran Jvan Essen GADuval XEsen MRespiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis2014;209:187381DOIPubMed
  31. Bigogo GMBreiman RFFeikin DRAudi AOAura BCosmas LEpidemiology of respiratory syncytial virus infection in rural and urban Kenya. J Infect Dis2013;208(Suppl 3):S20716DOIPubMed
  32. Pretorius MTempia SWalaza SCohen AMoyes JHellferscee OAssociation of influenza and other respiratory viruses with severe acute respiratory infection and influenza-like illness, relative to healthy controls in South Africa. In: Proceedings of the 8th Options for the Control of Influenza Conference, 5–10 September 2013, Cape Town, South Africa.
  33. Rowlinson EDueger ETaylor TMansour AVan Beneden CAbukela MIncidence and clinical features of respiratory syncytial virus infections in a population-based surveillance site in the Nile Delta Region. J Infect Dis2013;208(Suppl 3):S18996DOIPubMed
  34. McCracken JPPrill MMArvelo WLindblade KALópez MREstevez ARespiratory syncytial virus infection in Guatemala, 2007–2012. J Infect Dis.2013;208(Suppl 3):S197206DOIPubMed
  35. Naorat SChittaganpitch MThamthitiwat SHenchaichon SSawatwong PSrisaengchai PHospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008–2011. J Infect Dis2013;208(Suppl 3):S23845DOIPubMed
  36. Walsh EEFalsey ARRespiratory syncytial virus infection in adult populations. Infect Disord Drug Targets2012;12:98102DOIPubMed
  37. Piedra PAJewell AMCron SGAtmar RLGlezen WPCorrelates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine2003;21:347982DOIPubMed
  38. Pretorius MAMadhi SMCohen CNaidoo DGroome MMoyes JRespiratory viral co-infections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness—South Africa, 2009–2010. J Infect Dis.2012;206(Suppl 1):S15965DOIPubMed
  39. Goldstein EViboud CCharu VLipsitch MImproving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology.2012;23:82938DOIPubMed
  40. Bradshaw DPillay-Van Wyk VLaubscher RNojilana BGroenewald PNadine NCauses of death for South Africa: challenges and possibilities for improvement. South African Medical Research Council [cited 2013 Jun 12]. http://www.mrc.ac.za/bod/cause_death_statsSA.pdf

Figure

Tables

Technical Appendix

Suggested citation for this article: Tempia S, Walaza S, Viboud C, Cohen AL, Madhi SA, Venter M, et al. Deaths associated with respiratory syncytial and influenza viruses among persons >5 years of age in HIV-prevalent area, South Africa, 1998–2009. Emerg Infect Dis. 2015 Apr [date cited].http://dx.doi.org/10.3201/eid2103.141033
DOI: 10.3201/eid2104.141033
1Data from this study were presented in part at the Options for the Control of Influenza Conference VIII; 2013 Sep 5–10; Cape Town, South Africa.

No hay comentarios:

Publicar un comentario